类风湿性关节炎
药理学
关节炎
化学
CD44细胞
医学
毒性
内科学
细胞
生物化学
作者
Asiya Mahtab,Syed Arman Rabbani,Yub Raj Neupane,Shweta Pandey,Adil N. Ahmad,Mohd Ahmed Khan,Neha Gupta,Alka Madaan,Manu Jaggi,Nidhi Sandal,Harish Rawat,Mohd Aqil,Sushama Talegaonkar
标识
DOI:10.1016/j.carbpol.2020.116926
摘要
This research aims to coat Teriflunomide (TEF) loaded conventional nanoliposomes (CON-TEF-LIPO) with Chondroitin sulphate (CS) to produce CS-TEF-LIPO for the effective treatment of Rheumatoid arthritis (RA). Both CON-TEF-LIPO and CS-TEF-LIPO were produced, characterized and evaluated for their active targeting potential towards CD44 receptors. Cell cytotoxicity, cell viability and intracellular uptake study on differentiated U937 and MG-63 cells demonstrated the active targeting of CS-TEF-LIPO towards CD44 receptors. Furthermore, in vivo pharmacodynamic, biochemical, radiological and histopathological studies performed in adjuvant induced arthritic (AIA) rat model showed a significant (P < 0.05) reduction in inflammation in arthritic rat paw in CS-TEF-LIPO group compared to TEF and CON-TEF-LIPO groups. Moreover, liver toxicity study revealed that CS-TEF-LIPO showed no signs of toxicity and biodistribution study revealed the accumulation of CS-TEF-LIPO in synovial region of arthritic rat. Taken together, results suggest that CS-TEF-LIPO could provide a new insight for an effective treatment of RA.
科研通智能强力驱动
Strongly Powered by AbleSci AI